WJPR Citation New

  All Since 2020
 Citation  8502  4519
 h-index  30  23
 i10-index  227  96

Login

Best Article Awards

World Journal of Pharmaceutical Research (WJPR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.
Best Paper Award :
Dr. Dhrubo Jyoti Sen
Download Article: Click Here

Search

Track Your Article

Abstract

TYPE 2 DIABETICS MELLITUS CURED BY METFORMIN

Kiran Santosh Kapgate* and Upadesh B. Lade

Abstract

Metformin, a widely prescribed oral hypoglycemic agent, is used to treat type 2 diabetes by reducing appetite, inhibiting hepatic gluconeogenesis, and increasing glucose uptake by peripheral tissues. Metformin can prevent complications from high blood glucose but can negatively impact renal functions in T2DM patients, leading to chronic kidney disease. It can accumulate and cause lactic acidosis. Careful use is advised in elderly patients, those with trauma, fever, surgery, heart failure, or impaired kidney or liver functions. Moreover, the costeffectiveness of metformin has been established. Generally, metformin is an excellent choice both in the specialized setting and in primary health care.

Keywords: Diabetes mellitus, metformin, oral hypoglycemic agents, treatment, uses.


[Full Text Article]  [Download Certificate]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More